Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $104 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a $104 price target.
March 05, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Tenet Healthcare and maintained a $104 price target.
The reiteration of an Overweight rating and maintenance of a high price target by a reputable analyst like Sarah James from Cantor Fitzgerald could instill confidence among investors and potentially drive the stock price up in the short term. The specific mention of Tenet Healthcare and the optimistic price target highlight a strong positive outlook for the company.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100